0001062993-15-003496.txt : 20150622
0001062993-15-003496.hdr.sgml : 20150622
20150622145634
ACCESSION NUMBER: 0001062993-15-003496
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150422
FILED AS OF DATE: 20150622
DATE AS OF CHANGE: 20150622
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mattila Jyrki
CENTRAL INDEX KEY: 0001297318
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 15944533
MAIL ADDRESS:
STREET 1: AUXILIUM PHARMACEUTICALS, INC.
STREET 2: 40 VALLEY STREAM PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
4/A
1
form4a.xml
AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4/A
2015-04-22
2015-04-23
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001297318
Mattila Jyrki
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
0
0
0
Stock Option (Right to Buy)
37.64
2015-04-22
4
A
0
15000
0
A
2025-04-22
Common Stock
15000
15000
D
The purpose of this Form 4/A is solely to correct the exercise price of derivative securities granted to the reporting person and does not represent any acquisition or disposition of shares by the reporting person.
The options were granted on April 22, 2015 and will vest in four equal annual installments beginning on the first anniversary of the grant date.
/s/ Jyrki Mattila, by Carl A. Valenstein, attorney-in-fact
2015-06-22